Medtech cuts steal the show in Italy's much-maligned final budgetary law
This article was originally published in Clinica
Executive Summary
The final approval of Italy’s 2013 budgetary law at the end of December confirmed the Senate’s passage of medtech price caps, but the final text has other important implications for the medtech sector and wider healthcare industry.